Bevacizumab (Avastin) IV Solution from China
Bevacizumab is a humanized monoclonal antibody blocking VEGF, used for colorectal and lung cancer. Under HTS 3002.15.00.11 for its role in immunological regulation via angiogenesis inhibition, in retail-measured vials.
Duty Rate — China → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Include VEGF specificity test results and monoclonal purity assays in import docs
• Comply with USP <1079> for good distribution practices; avoid temperature excursions